|
- Semaglutide - ALZFORUM
Semaglutide is a synthetic, long-acting analog of glucagon-like peptide-1, used to treat diabetes Ozempic TM is a once-per-week injection formulation, while Rybelsus TM is is a daily pill Rybelsus TM was approved by the U S FDA in September 2019 as the first GLP-1 analog that does not need to be injected
- NT-0796 | ALZFORUM
In diet-induced obesity in these mice, NT-0796 caused weight loss as potently as did the GLP1 inhibitor semaglutide, and improved markers of cardiovascular risk (Thornton et al , 2024) It did not cause weight loss in non-obese mice Findings
- Semaglutide as a possible therapy for healthy aging: Targeting the . . .
Semaglutide as a possible therapy for healthy aging: Targeting the hallmarks of aging Ageing Res Rev 2024 Dec;102:102582 Epub 2024 Nov 14 PubMed Recommends Please login to recommend the paper Comments No Available Comments Make a Comment To make a comment you must login or register
- Neuroprotective Role of the Novel GLP-1R Agonist Semaglutide. | ALZFORUM
Kenzheshova A, Moldasheva A, Aljofan M Neuroprotective Role of the Novel GLP-1R Agonist Semaglutide Curr Med Chem 2025 Apr 23; Epub 2025 Apr 23 PubMed
- Therapeutics - ALZFORUM
Find a Therapeutic By Name Go NSC001 AAB-003 AADvac1 AAV-GAD AAV2-BDNF ABBV-1088 ABBV-552 ABBV-916 ABT 418 ABT-089 ABT-288 ABT-384 ABT-957 ABvac40 ACD856 Acetyl-l-carnitine HCI ACI-24 060 ACI-3024 ACI-7104 056 Acitretin ACP-204 ADEL-Y01 Aduhelm AF 102B Affitope AD02 AGB101 AIT-101 AKST4290 AL002 AL003 AL044 AL101 ALIA-1758 Allopregnanolone
- Semaglutide Attenuates Anxious and Depressive-Like Behaviors and . . .
Semaglutide Attenuates Anxious and Depressive-Like Behaviors and Reverses the Cognitive Impairment in a Type 2 Diabetes Mellitus Mouse Model Via the Microbiota-Gut-Brain Axis J Neuroimmune Pharmacol 2024 Jul 23;19(1):36
- The Discovery and Development of Liraglutide and Semaglutide . . . - ALZFORUM
The Discovery and Development of Liraglutide and Semaglutide Front Endocrinol (Lausanne) 2019;10:155 Epub 2019 Apr 12 PubMed Recommends Please login to recommend the paper Comments No Available Comments Make a Comment To make a comment you must login or register
- Could GLP-1 Receptor Agonists Like Semaglutide Treat Addiction . . .
Could GLP-1 Receptor Agonists Like Semaglutide Treat Addiction, Alzheimer Disease, and Other Conditions? JAMA 2024 May 14;331(18):1519-1521 PubMed Recommends Please login to recommend the paper Comments No Available Comments Make a Comment To make a comment you must login or register
|
|
|